Lucid Diagnostics Inc. Cash
Lucid Diagnostics Inc. (LUCD) had Cash of $33.40 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-12
- 2026-06-30: Cash $33.40M.
- 2026-03-31: Cash $27.88M.
- 2025-12-31: Cash $34.70M.
- 2025-09-30: Cash $47.30M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2026-06-30 | $33.40M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $27.88M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $34.70M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $47.30M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $31.10M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $25.20M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $22.36M 10-K · filed 2026-03-25 | $22.40M 10-K · filed 2025-03-24 |
| 2024-09-30 | $14.50M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $24.90M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $24.80M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $18.90M 10-K · filed 2024-03-25 | |
| 2022-06-30 | $32.68M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $47.92M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $53.66M 10-Q · filed 2022-08-15 | |
| 2021-09-30 | $21.34K 10-Q · filed 2021-11-23 | |
| 2020-12-31 | $111.00K 10-K · filed 2022-04-06 | $111.25K 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |